GlassScriptPhysician profile
Torsten J Kruse
NPI 1972644482
$2,287.88
in general payments reported to CMS, 2019-2025
23 companies · $535 in 2025
The $535 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $341 · 2020: $50.16 · 2021: $27.21 · 2022: $344 · 2023: $373 · 2024: $617 · 2025: $535.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,525.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,525.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $408.65 | 2019-2025 | Airsupra, Farxiga |
| Amgen INC. | $329.02 | 2019-2025 | Otezla, Repatha, Otezla |
| Novo Nordisk INC | $309.78 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Lilly USA, LLC | $235.05 | 2019-2025 | Mounjaro, Zepbound, Kisunla |
| Abbvie INC. | $223.96 | 2019-2025 | |
| Pfizer INC. | $133.80 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $124.51 | 2023-2024 | Xifaxan |
| Glaxosmithkline, LLC. | $67.13 | 2023-2025 | Shingrix, Arexvy |
| Janssen Pharmaceuticals, INC | $60.87 | 2019-2023 | Xarelto |
| Exact Sciences Corporation | $55.39 | 2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $47.00 | 2019-2023 | M-M-R II, Gardasil 9, Pneumovax 23 |
| Novartis Pharmaceuticals Corporation | $46.99 | 2022-2023 | |
| Bausch Health US, LLC | $41.20 | 2022-2024 | Aplenzin |
| Inari Medical, INC. | $32.85 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Sanofi Pasteur INC. | $25.00 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $25.00 | 2024 | Dexcom G6 Transmitter |
| Edwards Lifesciences Corporation | $24.79 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Takeda Pharmaceuticals U.S.A., INC. | $20.13 | 2019 | |
| Impel Pharmaceuticals INC. | $18.09 | 2022 | |
| Jazz Pharmaceuticals INC. | $16.63 | 2022 | |
| Neurocrine Biosciences, INC. | $14.83 | 2025 | |
| Alnylam Pharmaceuticals INC. | $14.37 | 2021 | |
| Ethicon INC. | $12.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Torsten Kruse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.